ScreenerHero
LBIRDLumibird SA
EPA · FR · Healthcare · Diagnostics & Research · lumibird.com
26.00EUR-0.38%Mkt Cap: 624.79M $P/E: 40.70

Lumibird SA designs, manufactures, and sells various lasers for scientific, industrial, and medical applications in France, Hong Kong, the United States, Germany, South Korea, China, and Austria. The company operates thr…

Industry Peers

Diagnostics & Research
Screen all
TMO
Thermo Fisher Scientific Inc.
$226.85BUSDP/E 33.1
DHR
Danaher Corporation
$151.78BUSDP/E 38.6
LONN
Lonza Group Ltd
$46.70BUSDP/E 37.9
NTRA
Natera, Inc.
$46.86BUSD
IDXX
IDEXX Laboratories, Inc.
$44.35BUSDP/E 39.5
A
Agilent Technologies, Inc.
$44.14BUSDP/E 31.4
IQV
IQVIA Holdings Inc
$41.03BUSDP/E 31.0
WAT
Waters Corporation
$40.83BUSDP/E 105.8
ILMN
Illumina, Inc.
$30.95BUSDP/E 38.2
MTD
Mettler-Toledo International, Inc.
$28.55BUSDP/E 32.1
LH
Labcorp Holdings Inc.
$26.80BUSDP/E 27.4
DGX
Quest Diagnostics Incorporated
$26.68BUSDP/E 25.6
GH
Guardant Health, Inc.
$21.92BUSD
MEDP
Medpace Holdings, Inc.
$16.98BUSDP/E 35.8
ERF
Eurofins Scientific SE
$13.65BUSDP/E 25.3
CRL
Charles River Laboratories International, Inc.
$13.84BUSD
RVTY
Revvity Inc. Common Stock
$13.33BUSDP/E 57.4
BIM
bioMérieux S.A.
$9.55BUSDP/E 19.1
QIA
Qiagen N.V.
$8.69BUSDP/E 22.8
TWST
Twist Bioscience Corp.
$8.93BUSD

Key Statistics

Company
Market Cap624.79M $
Enterprise Value719.02M $
Revenue (TTM)248.40M $
Gross Profit158.96M $
Net Income (TTM)15.23M $
Revenue/Share11.28 USD
Last Price26.00 EUR
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees1.1K
CountryFR
SectorHealthcare
IndustryDiagnostics & Research
ISIN—
Valuation
P/E (Trailing)40.70
P/E (Forward)20.75
PEG—
EV/EBITDA20.39
EV/Revenue2.89
P/S2.52
P/B2.79
EPS (TTM)0.64
EPS (Forward)1.26
52W Range
15.7579% of range28.70
52W High28.70 EUR
52W Low15.75 EUR
Profitability
Gross Margin63.99%
Oper. Margin13.36%
EBITDA Margin14.20%
Profit Margin6.13%
ROE6.79%
ROA3.27%
Growth
Revenue Growth8.50%
Earnings Growth58.50%
Cash Flow & Leverage
Operating CF31.52M $
CapEx (TTM)17.78M $
FCF Margin1.58%
FCF Yield0.63%
Net Debt91.83M $
Net Debt/EBITDA2.60
Balance Sheet
Debt/Equity0.71
Current Ratio2.47
Quick Ratio1.52
Book Value/Sh9.366 EUR
Cash/Share2.796 EUR
Dividends
Fwd Div Rate0.3700 EUR
Trail. Div Rate0.0000 EUR
Div. Yield1.38%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div DateMay 18, 2026
Pay Date—
Analyst Consensus
Rating—
Target (Mean)32.17 EUR
Upside (mean)+23.7%
Target Range30.00 EUR – 35.00 EUR
€30.00+23.7% to mean€35.00
# Analysts3
Ownership
Shares Out.22.07M
Float10.38M
Insiders53.58%
Institutions17.71%
Technical
SMA 5026.21 (-0.8%)
SMA 20023.24 (+11.9%)
Beta0.94
S&P 52W Chg18.16%
Avg Vol (30d)24.28K
Avg Vol (10d)24.87K
Technical Indicators
RSI (14)41.4
MACD0.1789
MACD Signal0.3459
MACD Hist.-0.1671
BB Upper28.39 EUR
BB Middle27.09 EUR
BB Lower25.78 EUR
BB Width9.66%
ATR (14)0.8415 EUR
Vol Ratio (20d)0.86x